SCHEMBL10010220

SCHEMBL10010220

CC1(C)c2ccccc2-c2c1cc(-c1c3ccccc3c(-c3ccc(C(=O)c4ccccc4)cc3)c3ccccc13)c1ccccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDK2 Q15119 2/20 0.40
▸ MAPT P10636 2/20 0.38
▸ RAB9A P51151 2/20 0.38
▸ MEN1 O00255 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ CNR2 P34972 5/20 0.38
▸ RARB P10826 1/20 0.36
▸ RARG P13631 1/20 0.36
▸ RXRA P19793 1/20 0.36
▸ CNR1 P21554 3/20 0.36
▸ GAA P10253 1/20 0.36
▸ NPSR1 Q6W5P4 1/20 0.36
▸ ALDH1A1 P00352 1/20 0.35
▸ ATM Q13315 1/20 0.35
▸ TDP1 Q9NUW8 1/20 0.35
▸ L3MBTL1 Q9Y468 1/20 0.35
▸ SRD5A2 P31213 1/20 0.35
▸ MMP2 P08253 1/20 0.35
▸ MMP3 P08254 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12952451 0.95 PDK2 (0.40) PDK2MAPTRAB9AMEN1LMNA
SCHEMBL13150088 0.93 CNR2 (0.36) PDK2MAPTRAB9AMEN1LMNA
SCHEMBL13025511 0.91 PDK2 (0.36) PDK2MAPTRAB9AMEN1LMNA
SCHEMBL12337213 0.82 PDK2 (0.40) PDK2MAPTRAB9AMEN1LMNA
SCHEMBL13150131 0.81 — —
SCHEMBL10010621 0.80 ACHE (0.39) PDK2MEN1KMT2ANPSR1L3MBTL1
SCHEMBL10010634 0.80 — —
SCHEMBL10010022 0.80 PDK2 (0.30) PDK2
SCHEMBL10010292 0.80 ACHE (0.33) PDK2MAPTALDH1A1TDP1L3MBTL1
SCHEMBL2606597 0.78 PDK2 (0.37) PDK2MAPTRAB9AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 — — US disclosed
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME Rohm and Haas Electronic Materials Korea Let. (KR) 2012-04-19 — — US disclosed
WO-2010114266-A2 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME DOW ADVANCED DISPLAY MATERIALS,LTD. (KR) 2010-10-07 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120091885-A1 NOVEL ORGANIC ELECTROLUMINESCENT COMPOUNDS AND ORGANIC ELECTROLUMINESCENT DEVICE USING THE SAME OCIAD1, OCIAD2, ODC1 PDK2 1146/4885MAPT 1811/4885RAB9A 1793/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback